Physician profile
Jason Reagor
NPI 1164058772
$4,847.30
in general payments reported to CMS, 2019-2025
9 companies · $3,798 in 2025
The $3,798 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $454 · 2023: $263 · 2024: $333 · 2025: $3,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,139 · Food and Beverage: $1,255 · Grant: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,138.54 |
| Food and Beverage | $1,255.07 |
| Grant | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,707.60 | 2025 | Accolade Sr, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $1,000.00 | 2025 | |
| Silk Road Medical, INC. | $572.04 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Inari Medical, INC. | $204.50 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Integra Lifesciences Corporation | $113.62 | 2022 | |
| Cardiovascular Systems INC. | $93.30 | 2022 | |
| Stryker Corporation | $90.09 | 2025 | Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $33.42 | 2022 | |
| Terumo Medical Corporation | $32.73 | 2023-2024 | Glidewire, Metacross Otw |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Reagor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.